Metastatic malignant solid neoplasm is a medical condition with active clinical research programs worldwide.

11 total trials for this combination

Showing top 10 of 11 trials

Trials

NCT ID	Title	Status	Phase
NCT04585958	Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer	RECRUITING	PHASE1
NCT04387656	NCI COVID-19 in Cancer Patients, NCCAPS Study	ACTIVE_NOT_RECRUITING	—
NCT01012817	Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer	ACTIVE_NOT_RECRUITING	PHASE1/PHASE2
NCT06745024	Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT Trial	RECRUITING	PHASE3
NCT06349642	Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform	RECRUITING	—
NCT02898207	Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer	COMPLETED	PHASE1
NCT05455606	Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment	ACTIVE_NOT_RECRUITING	NA
NCT04514497	Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer	ACTIVE_NOT_RECRUITING	PHASE1
NCT05564377	Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial	RECRUITING	—
NCT03994796	Genetic Testing in Guiding Treatment for Patients With Brain Metastases	SUSPENDED	PHASE2

Related Pages

All Metastatic malignant solid neoplasm trials All trials in Phoenix, United States